NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
First Claim
Patent Images
1. A method for treating cancer by administering a composition to a subject in need thereof, wherein the composition comprises:
- an anti-transferrin receptor antibody or its binding fragments thereof; and
a double-stranded siRNA molecule consisting of a passenger strand and a guide strand;
wherein said double-stranded siRNA molecule is conjugated to a cysteine of said antibody by a linker;
wherein said double-stranded siRNA molecule comprises at least one 2′
modified nucleotide, at least one modified internucleotide linkage, or at least one inverted abasic moiety; and
wherein the linker is conjugated to the 5′
terminus of the passenger strand of said double stranded siRNA molecule.
3 Assignments
0 Petitions
Accused Products
Abstract
Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.
2 Citations
20 Claims
-
1. A method for treating cancer by administering a composition to a subject in need thereof, wherein the composition comprises:
-
an anti-transferrin receptor antibody or its binding fragments thereof; and a double-stranded siRNA molecule consisting of a passenger strand and a guide strand; wherein said double-stranded siRNA molecule is conjugated to a cysteine of said antibody by a linker; wherein said double-stranded siRNA molecule comprises at least one 2′
modified nucleotide, at least one modified internucleotide linkage, or at least one inverted abasic moiety; andwherein the linker is conjugated to the 5′
terminus of the passenger strand of said double stranded siRNA molecule. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification